AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
EMPAGLIFLOZIN 25 Mg ; METFORMIN HYDROCHLORIDE 1000 Mg ;
11 registrations across 1 African market— 11 active
Markets with EMPAGLIFLOZIN 25 Mg ; METFORMIN HYDROCHLORIDE 1000 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Andoflozin 25/1000 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| Downbetes 25/1000 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Utopia pharmaceuticals | active | — |
| Downbetes 25/1000 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Utopia pharmaceuticals | active | — |
| Empagliform XR 25/1000 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Hikma pharma | active | — |
| Mellitofix Met 25/1000 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Rametalina 25mg/1000mg Extended Release Film Coated Tablets | 🇪🇬Egypt | The Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA" | active | — |
| Empacombomet 25/1000 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Zeta Pharma for Pharmaceutical Industries (Zeta Pharma) | active | — |
| Empagliform XR 25/1000 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Hikma pharma | active | — |
| Andoflozin 25/1000 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| Empacombomet 25/1000 mg Extended Release Film Coated Tablets | 🇪🇬Egypt | Zeta Pharma for Pharmaceutical Industries (Zeta Pharma) | active | — |
| Rametalina 25mg/1000mg Extended Release Film Coated Tablets | 🇪🇬Egypt | The Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA" | active | — |
EMPAGLIFLOZIN 25 Mg ; METFORMIN HYDROCHLORIDE 1000 Mg ; in Africa — Regulatory Overview
EMPAGLIFLOZIN 25 Mg ; METFORMIN HYDROCHLORIDE 1000 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.